Home
Scholarly Works
Initial reporting of NRG-LU001 (NCT02186847),...
Conference

Initial reporting of NRG-LU001 (NCT02186847), randomized phase II trial of concurrent chemoradiotherapy (CRT) plus /- metformin in locally advanced Non-Small Cell Lung Cancer (NSCLC).

Authors

Tsakiridis T; Hu C; Skinner HD; Santana-Davila R; Lu B; Erasmus JJ; Doemer A; Videtic GMM; Coster J; Yang X

Volume

37

Publisher

AMER SOC CLINICAL ONCOLOGY

Publication Date

May 20, 2019

Name of conference

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Conference place

IL, Chicago

Conference start date

May 31, 2019

Conference end date

June 4, 2019

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

15

ISSN

0732-183X

Labels

Fields of Research (FoR)

Contact the Experts team